全球呼吸治疗设备市场

到 2030 年，全球呼吸治疗设备市场规模将达到 17 亿美元

全球呼吸治疗设备市场规模预计在2024年达到14亿美元，预计在2024-2030年的分析期内将以3.6%的复合年增长率增长，到2030年将达到17亿美元。诊断设备是本报告分析的细分市场之一，预计其复合年增长率为2.9%，到分析期末将达到10亿美元。治疗设备细分市场在分析期间内的复合年增长率预计为4.7%。

美国市场规模估计为 3.833 亿美元，中国市场预计复合年增长率为 6.6%

美国呼吸治疗设备市场规模预计2024年达到3.833亿美元。作为世界第二大经济体，中国市场规模预计到2030年将达到3.465亿美元，在2024-2030年的分析期间内，复合年增长率为6.6%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为1.5%和2.8%。在欧洲，预计德国市场的复合年增长率为2.1%。

全球呼吸治疗设备市场—主要趋势与驱动因素摘要

气道内技术的进步如何改变肺部介入手术

什么增强了内视镜检查在慢性和急性呼吸道疾病管理中的作用？

随着肺部医学向更微创、更精准的介入治疗转型，用于诊断和治疗慢性和急性气道疾病，呼吸治疗市场正在迅速发展。慢性慢性阻塞性肺病(COPD)、支气管狭窄、中央气道阻塞和肺癌等疾病通常需要内视镜治疗，包括扩张、支架置入和阻塞气道切除。这些治疗越来越多地采用先进的内视镜治疗设备进行，例如球囊扩张器、电外科探头、冷冻治疗系统和气道支架，从而能够在最大程度减少对周围组织损伤的情况下进行标靶治疗。

城市污染、吸烟、人口老化和新冠併发症加剧了呼吸系统疾病的负担，迫切需要无需大手术即可缓解呼吸系统疾病的技术。在这方面，内视镜治疗具有多种优势，包括门诊治疗选择、恢復时间短和併发症风险低。例如，在肺癌病例中，支气管镜治疗不仅越来越多地用于姑息减压，而且还用于动态疗法和近距离放射治疗等局部治疗。这种转变得益于影像导引导航和微型仪器的改进，它们提高了手术安全性和诊断准确性，使肺病专家能够更精确地进入更深的肺段。

设备和诊断影像方面的哪些创新正在改变内视镜治疗设备的性能？

科技创新正在重塑呼吸治疗设备的性能、设计和应用。其中一项关键进展是可操控一次性支气管镜的开发，它能够改善在复杂气道解剖结构中的导航能力，同时降低交叉污染的风险。这些一次性设备与即时萤光透视和电磁导航系统相结合，使临床医生能够治疗先前难以触及的病变。此外，具有可调节充气曲线的球囊扩张系统能够实现渐进式压力控制，从而降低扩张手术中气道损伤的风险。

另一个重要趋势是电外科和冷冻消融设备的小型化及其与支气管镜平台的整合。冷冻探针可以精确冷冻异常组织以进行切片检查或切除，现在已有多种灵活的形式，适用于外周肺部手术。同样，氩离子凝固术 (APC) 和射频消融术 (RFA) 也正在被改进用于经支气管手术，以抑制咯血和切除肿瘤。先进的支架输送系统——通常预先安装、自膨胀且长度和直径可客製化——正在改善气道狭窄和术后狭窄的治疗效果。此外，内视镜器械越来越多地配备感测器，可提供温度、压力和定位的即时回馈，从而最大限度地减少人为错误并提高手术的可重复性。

临床方案和当地医疗保健基础设施将如何影响市场渗透？

肺部治疗设备的采用在很大程度上受到当地临床通讯协定、报销框架和介入性肺部基础设施可用性的影响。在美国、德国、日本和韩国等高高所得地区，肺部治疗正日益被三级医疗中心采用，成为诊断和治疗的标准护理。这些国家的医院拥有先进的影像设备、一体化手术室以及训练有素的介入性肺部专科医生，他们能够使用各种设备。这些地区也建立了微创手术和急性期后肺部护理的报销制度，进一步促进了肺部治疗设备的采用。

相较之下，东南亚、东欧和拉丁美洲等中等收入地区对肺内治疗的兴趣日益浓厚，但其应用往往受到成本和专业技术匮乏的限制。然而，日益壮大的官民合作关係和基于远端医疗的培训平台正在帮助弥合技术差距。在印度、中国和巴西，政府和非营利倡议旨在早期发现和管理呼吸系统疾病的倡议，正在刺激对经济高效、适应当地情况的内视镜解决方案的需求。移动支气管镜检查单元和门诊介入计画开始在都市区医院兴起，使更广泛的患者群体能够获得内视镜治疗。

什么将支持呼吸治疗市场的长期成长？

呼吸治疗市场的成长受到多种因素的推动，包括慢性呼吸系统疾病盛行率的上升、对微创干预的需求不断增长以及手术工具的持续技术创新。一个关键的成长要素是向门诊护理模式和门诊病人介入的转变。医疗保健系统面临着降低住院费用和手术併发症的压力，而内视镜支气管镜检查提供了一种可行的替代方案，符合基于价值的医疗目标。呼吸系统和胸部疾病早期诊断的增加进一步推动了对内视镜支气管镜检查的需求，这些疾病通常透过低剂量电脑断层扫描和人工智慧辅助X光检查检测出来。

此外，介入病理学作为一个独特的次专科，其作用日益扩大，为先进内视镜治疗工具的应用奠定了坚实的临床基础。医院和训练中心正在投资模拟实验室、混合手术室和人工智慧引导的手术规划系统，以支援新一代肺科专家。在技​​术方面，机器人技术、成像技术和材料科学的日益融合，正在释放自主导航、精准药物传输和具有抗炎特性的奈米涂层支架的潜力。

最后，以呼吸健康为重点的全球卫生政策倡议，例如世界卫生组织的《预防和控制非传染性疾病全球行动计画》，正在为该领域的投资和创新创造有利的政策环境。由于人口老化、都市区发病率上升以及呼吸道流行病的持续威胁，内视镜治疗在肺部健康管理中的作用预计将显着提升。未来的医疗设备预计将变得更加经济实惠、个人化和数位化，从而确保这一影响深远的医疗领域的长期成长轨迹。

部分

设备（诊断设备、治疗设备）、专业人员（医院专业人员、诊断中心专业人员、门诊手术中心专业人员）、最终使用者（週边介入最终使用者、血管内介入最终使用者、心臟最终使用者、介入放射学最终使用者、静脉最终使用者、其他最终使用者）

受访公司范例

• Ambu
• Armstrong Medical
• Boston Scientific
• CONMED Corporation
• Cook Medical
• Dragerwerk
• Fisher & Paykel Healthcare
• Flexicare Medical
• Getinge
• Halyard Health（Avanos Medical）
• Hudson RCI
• Intersurgical
• Karl Storz
• Laerdal Medical
• Medtronic
• Olympus
• PENTAX Medical
• Philips（Philips Respironics）
• ResMed
• Teleflex

人工智慧集成

我们正在利用有效的专家内容和人工智慧工具来改变市场和竞争情报。

Global Industry Analysts 没有遵循查询 LLM 或特定产业SLM 的典型规范，而是建立了一个来自世界各地专家的精选内容库，其中包括视频录像、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

• 市场概览
• 主要企业
• 市场趋势和驱动因素
• 全球市场展望

第三章市场分析

• 美国
• 加拿大
• 日本
• 中国
• 欧洲
• 法国
• 德国
• 义大利
• 英国
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 澳洲
• 印度
• 韩国
• 其他亚太地区
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中东
• 伊朗
• 以色列
• 沙乌地阿拉伯
• 阿拉伯聯合大公国
• 其他中东地区
• 非洲

第四章 竞赛

Global Respiratory Endotherapy Devices Market to Reach US$1.7 Billion by 2030

The global market for Respiratory Endotherapy Devices estimated at US$1.4 Billion in the year 2024, is expected to reach US$1.7 Billion by 2030, growing at a CAGR of 3.6% over the analysis period 2024-2030. Diagnostic Devices, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$1.0 Billion by the end of the analysis period. Growth in the Therapeutic Devices segment is estimated at 4.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$383.3 Million While China is Forecast to Grow at 6.6% CAGR

The Respiratory Endotherapy Devices market in the U.S. is estimated at US$383.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$346.5 Million by the year 2030 trailing a CAGR of 6.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.5% and 2.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.1% CAGR.

Global Respiratory Endotherapy Devices Market - Key Trends & Drivers Summarized

Inside the Airway: How Technological Advancements Are Transforming Interventional Pulmonary Procedures

What Is Elevating the Role of Endotherapy in Managing Chronic and Acute Respiratory Disorders?

The respiratory endotherapy devices market is rapidly gaining prominence as pulmonology transitions toward less invasive, precision-guided interventions for the diagnosis and treatment of both chronic and acute airway disorders. Conditions such as chronic obstructive pulmonary disease (COPD), bronchial stenosis, central airway obstruction, and lung cancers often require therapeutic endoscopy involving dilation, stenting, or ablation of obstructed airways. These interventions are increasingly being performed using advanced endotherapy devices, including balloon dilators, electrosurgical probes, cryotherapy systems, and airway stents, which enable targeted treatment with minimal trauma to surrounding tissues.

The rising burden of respiratory diseases-exacerbated by urban pollution, smoking, aging populations, and post-COVID complications-has created an urgent need for technologies that provide relief without resorting to major surgery. Endotherapy offers several advantages in this regard, such as outpatient feasibility, shorter recovery time, and lower risk of complications. In the context of lung cancer, for instance, bronchoscopic interventions are being used not only for palliative decompression but also for delivering localized therapy such as photodynamic treatment or brachytherapy. These shifts are supported by improvements in imaging-guided navigation and miniaturized instrumentation that enhance procedural safety and diagnostic accuracy, allowing pulmonologists to access deeper lung segments with higher precision.

What Innovations in Instrumentation and Imaging Are Transforming Endotherapy Device Performance?

Technological innovation is reshaping the performance, design, and application of respiratory endotherapy devices. One of the major advancements is the development of steerable, single-use bronchoscopes that reduce cross-contamination risks while improving navigation in complex airway anatomies. These disposable devices, paired with real-time fluoroscopy or electromagnetic navigation systems, enable clinicians to deliver therapy to previously inaccessible lesions. Moreover, balloon dilation systems with adjustable inflation profiles now provide graduated pressure control, reducing the risk of airway trauma during dilation procedures.

Another significant trend is the miniaturization and integration of electrosurgical and cryoablation devices into bronchoscopic platforms. Cryoprobes, capable of precisely freezing abnormal tissue for biopsy or ablation, are now available in flexible formats suitable for peripheral lung procedures. Similarly, argon plasma coagulation (APC) and radiofrequency ablation (RFA) tools are being adapted for transbronchial use to control hemoptysis or debulk tumors. Advanced stent delivery systems-often preloaded, self-expanding, and customizable in length and diameter-are improving treatment outcomes in airway stenosis and post-surgical strictures. Furthermore, endotherapy devices are now being designed with embedded sensors for real-time feedback on temperature, pressure, and positioning, thereby minimizing human error and enhancing procedural reproducibility.

How Do Clinical Protocols and Regional Healthcare Infrastructure Shape Market Penetration?

The adoption of respiratory endotherapy devices is highly influenced by local clinical protocols, reimbursement frameworks, and the availability of interventional pulmonology infrastructure. In high-income regions such as the U.S., Germany, Japan, and South Korea, respiratory endotherapy is increasingly being adopted as standard-of-care in tertiary centers for both diagnostic and therapeutic purposes. Hospitals in these countries are equipped with advanced imaging modalities, integrated operating suites, and trained interventional pulmonologists who can utilize the full spectrum of devices. Reimbursement for minimally invasive procedures and post-acute respiratory care is also well established in these regions, further encouraging adoption.

In contrast, middle-income regions such as Southeast Asia, Eastern Europe, and Latin America are witnessing growing interest in respiratory endotherapy, but uptake is often constrained by cost considerations and limited technical expertise. Nevertheless, the expansion of public-private partnerships and telemedicine-based training platforms is helping to bridge the skills gap. In India, China, and Brazil, government and non-profit initiatives targeting early detection and management of respiratory diseases are spurring demand for cost-effective, locally adapted endotherapy solutions. Mobile bronchoscopy units and outpatient interventional programs are beginning to appear in urban hospitals, bringing endotherapy within reach of a broader patient demographic.

What Is Sustaining Long-Term Growth in the Respiratory Endotherapy Devices Market?

The growth in the respiratory endotherapy devices market is driven by several factors, including the increasing prevalence of chronic respiratory diseases, rising demand for minimally invasive interventions, and ongoing innovation in procedural tools. A major growth driver is the shift toward ambulatory care models and outpatient interventions. With healthcare systems under pressure to reduce inpatient costs and surgical complications, bronchoscopic endotherapy provides a viable alternative that aligns with the goals of value-based care. The demand for these procedures is further fueled by the rise in early diagnosis of respiratory and thoracic conditions, often detected through low-dose CT scans and AI-assisted radiology.

In addition, the expanding role of interventional pulmonology as a distinct subspecialty is creating a robust clinical base for the adoption of advanced endotherapy tools. Hospitals and training centers are investing in simulation labs, hybrid ORs, and AI-guided procedural planning systems to support a new generation of pulmonary specialists. From a technology standpoint, the ongoing convergence of robotics, imaging, and material science is unlocking possibilities such as autonomous navigation, precision drug delivery, and nanocoated stents with anti-inflammatory properties.

Finally, global health policy initiatives focusing on respiratory health-such as the WHO’s Global Action Plan for the Prevention and Control of NCDs-are creating a favorable policy environment for investment and innovation in this domain. With aging populations, rising urban morbidity, and the continuing threat of respiratory pandemics, the role of endotherapy in managing pulmonary health is set to grow substantially. Future devices are expected to become more affordable, personalized, and digitally connected, securing a long-term trajectory of growth for this high-impact medical segment.

SCOPE OF STUDY:

The report analyzes the Respiratory Endotherapy Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Device (Diagnostic Devices, Therapeutic Devices); Specialist (Hospitals Specialist, Diagnostic Centers Specialist, Ambulatory Surgery Centers Specialist); End-Use (Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use, Interventional Radiology End-Use, Venous End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• Ambu
• Armstrong Medical
• Boston Scientific
• CONMED Corporation
• Cook Medical
• Dragerwerk
• Fisher & Paykel Healthcare
• Flexicare Medical
• Getinge
• Halyard Health (Avanos Medical)
• Hudson RCI
• Intersurgical
• Karl Storz
• Laerdal Medical
• Medtronic
• Olympus
• PENTAX Medical
• Philips (Philips Respironics)
• ResMed
• Teleflex

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Respiratory Endotherapy Devices - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Incidence of Chronic Respiratory Diseases Propels Demand for Endotherapy Interventions
  • Aging Global Population Base Strengthens Business Case for Minimally Invasive Pulmonary Procedures
  • Increased Diagnosis Rates of COPD and Asthma Accelerate Device Utilization in Bronchoscopic Therapies
  • Advances in Flexible Endoscopic Technologies Expand Addressable Market for Precision Treatment
  • Surge in Demand for Non-Surgical Alternatives Spurs Adoption of Respiratory Endotherapy Devices
  • Integration of Imaging-Guided Navigation Systems Enhances Procedure Success and Market Uptake
  • Emergence of Endobronchial Valves and Coils Drives Innovation in Severe Emphysema Treatment
  • Growing Focus on Daycare and Outpatient Bronchoscopy Strengthens Demand for Disposable Instruments
  • Hospital Budget Constraints Propel Preference for Reusable and Sterilizable Device Configurations
  • Expanding Adoption in Lung Cancer Diagnosis and Palliative Care Broadens Use-Case Scenarios
  • Clinical Trials and Regulatory Approvals Accelerate Market Penetration of Novel Endotherapy Solutions
  • Public and Private Investment in Respiratory Research Fuels Device Development Pipelines
  • Increased Demand for Airway Stenting and Dilatation Enhances Market Versatility
  • High Burden of Smoking-Related Lung Damage Throws the Spotlight on Therapeutic Endoscopy
  • Integration with AI-Based Bronchoscopic Mapping Systems Drives Procedural Efficiency
  • Surge in ICU Admissions and Ventilation-Related Complications Boosts Procedural Frequency
  • Training and Simulation Tools Enhance Adoption Rates Among Pulmonologists and Interventionalists
  • Decentralization of Respiratory Care to Ambulatory Settings Expands Market Reach
  • Innovations in Biodegradable Implants Open New Frontiers in Chronic Disease Management
  • Rising Healthcare Spending in Emerging Markets Spurs Procurement of Advanced Endotherapy Systems
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Respiratory Endotherapy Devices Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Respiratory Endotherapy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Respiratory Endotherapy Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Diagnostic Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Diagnostic Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Diagnostic Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Therapeutic Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Therapeutic Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Therapeutic Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Venous End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Venous End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Venous End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Peripheral Vascular Intervention End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Peripheral Vascular Intervention End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Peripheral Vascular Intervention End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Endovascular Interventions End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Endovascular Interventions End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Endovascular Interventions End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Cardiac End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Cardiac End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Cardiac End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Interventional Radiology End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Interventional Radiology End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Interventional Radiology End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Hospitals Specialist by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Hospitals Specialist by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 31: World 16-Year Perspective for Hospitals Specialist by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Diagnostic Centers Specialist by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Diagnostic Centers Specialist by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 34: World 16-Year Perspective for Diagnostic Centers Specialist by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers Specialist by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Ambulatory Surgery Centers Specialist by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 37: World 16-Year Perspective for Ambulatory Surgery Centers Specialist by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Respiratory Endotherapy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 38: USA Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 40: USA 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
  • TABLE 41: USA Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 43: USA 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 46: USA 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 49: Canada 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 52: Canada 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 55: Canada 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
• JAPAN
  • Respiratory Endotherapy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 58: Japan 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 61: Japan 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 64: Japan 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
• CHINA
  • Respiratory Endotherapy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 65: China Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 67: China 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
  • TABLE 68: China Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 70: China 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
  • TABLE 71: China Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 73: China 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
• EUROPE
  • Respiratory Endotherapy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Respiratory Endotherapy Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 76: Europe 16-Year Perspective for Respiratory Endotherapy Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 79: Europe 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 82: Europe 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 85: Europe 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
• FRANCE
  • Respiratory Endotherapy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 86: France Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: France Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 88: France 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
  • TABLE 89: France Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 91: France 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
  • TABLE 92: France Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: France Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 94: France 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
• GERMANY
  • Respiratory Endotherapy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 95: Germany Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 97: Germany 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
  • TABLE 98: Germany Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 100: Germany 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
  • TABLE 101: Germany Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Germany Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 103: Germany 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 104: Italy Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 106: Italy 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
  • TABLE 107: Italy Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 109: Italy 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
  • TABLE 110: Italy Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Italy Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 112: Italy 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Respiratory Endotherapy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 113: UK Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 115: UK 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
  • TABLE 116: UK Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 118: UK 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
  • TABLE 119: UK Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: UK Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 121: UK 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 122: Spain Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 124: Spain 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
  • TABLE 125: Spain Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 127: Spain 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
  • TABLE 128: Spain Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 130: Spain 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 131: Russia Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 133: Russia 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 136: Russia 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
  • TABLE 137: Russia Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 139: Russia 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 142: Rest of Europe 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 148: Rest of Europe 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Respiratory Endotherapy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Respiratory Endotherapy Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 16-Year Perspective for Respiratory Endotherapy Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Respiratory Endotherapy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 161: Australia Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 163: Australia 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
  • TABLE 164: Australia Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 166: Australia 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
  • TABLE 167: Australia Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Australia Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 169: Australia 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
• INDIA
  • Respiratory Endotherapy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 170: India Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: India Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 172: India 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
  • TABLE 173: India Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 175: India 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
  • TABLE 176: India Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: India Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 178: India 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 181: South Korea 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 184: South Korea 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
  • TABLE 185: South Korea Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: South Korea Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 187: South Korea 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
  • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Asia-Pacific Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 196: Rest of Asia-Pacific 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Respiratory Endotherapy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Respiratory Endotherapy Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 199: Latin America 16-Year Perspective for Respiratory Endotherapy Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 202: Latin America 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 205: Latin America 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 208: Latin America 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 211: Argentina 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 214: Argentina 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
  • TABLE 215: Argentina Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Argentina Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 217: Argentina 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 220: Brazil 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 223: Brazil 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
  • TABLE 224: Brazil Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Brazil Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 226: Brazil 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 229: Mexico 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 232: Mexico 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
  • TABLE 233: Mexico Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Mexico Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 235: Mexico 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 238: Rest of Latin America 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
  • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Latin America Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 244: Rest of Latin America 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Respiratory Endotherapy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Respiratory Endotherapy Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 247: Middle East 16-Year Perspective for Respiratory Endotherapy Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 250: Middle East 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 253: Middle East 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 256: Middle East 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 257: Iran Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 259: Iran 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
  • TABLE 260: Iran Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 262: Iran 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
  • TABLE 263: Iran Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Iran Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 265: Iran 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 266: Israel Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 268: Israel 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
  • TABLE 269: Israel Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 271: Israel 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
  • TABLE 272: Israel Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Israel Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 274: Israel 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 277: Saudi Arabia 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
  • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Saudi Arabia Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 283: Saudi Arabia 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 284: UAE Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 286: UAE 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
  • TABLE 287: UAE Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 289: UAE 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
  • TABLE 290: UAE Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: UAE Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 292: UAE 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 295: Rest of Middle East 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
  • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Middle East Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 301: Rest of Middle East 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030
• AFRICA
  • Respiratory Endotherapy Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 302: Africa Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for Respiratory Endotherapy Devices by Device - Diagnostic Devices and Therapeutic Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 304: Africa 16-Year Perspective for Respiratory Endotherapy Devices by Device - Percentage Breakdown of Value Sales for Diagnostic Devices and Therapeutic Devices for the Years 2014, 2025 & 2030
  • TABLE 305: Africa Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for Respiratory Endotherapy Devices by End-Use - Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 307: Africa 16-Year Perspective for Respiratory Endotherapy Devices by End-Use - Percentage Breakdown of Value Sales for Venous End-Use, Other End-Uses, Peripheral Vascular Intervention End-Use, Endovascular Interventions End-Use, Cardiac End-Use and Interventional Radiology End-Use for the Years 2014, 2025 & 2030
  • TABLE 308: Africa Recent Past, Current & Future Analysis for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Africa Historic Review for Respiratory Endotherapy Devices by Specialist - Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 310: Africa 16-Year Perspective for Respiratory Endotherapy Devices by Specialist - Percentage Breakdown of Value Sales for Hospitals Specialist, Diagnostic Centers Specialist and Ambulatory Surgery Centers Specialist for the Years 2014, 2025 & 2030

IV. COMPETITION